A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.
Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...
In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...
Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.
Although the respiratory season in Hungary has eased for the second week in a row, there were still almost 100 children under the age of two in hospital with severe acute respiratory infection, and 57 ...
A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...
Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...
On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants ...
FRESNO, Calif. (KFSN) -- The cold winter months kept Central California doctors busy, from the flu to COVID and even RSV. "We ...
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
A recent study reveals that infants and young children are the primary transmitters of respiratory syncytial virus (RSV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback